Now Enrolling – COVID-19 Vaccine Booster study
Take Action Against COVID-19
The BNT162-17 study is a two-part research study that is examining the safety and efficacy of
investigational vaccine booster regimens to prevent COVID-19 (including the delta variant).
Volunteers may be eligible to participate if they:
- Are between 18 and 85 years old
- Have previously received the BNT162b2 vaccine (also known as the Pfizer-BioNTech vaccine; 30 µg, two-dose regimen) at least 6 months ago or have not previously received vaccination for COVID-19
- Have no history of COVID-19 and/or clinical evidence of prior infection at screening
- Have no known history of HBV or HIV
- Have had no previous allergic reactions to vaccines
By taking part in this study, volunteers will receive:
- COVID-19 vaccination or booster
- Study-related assessments and medical testing throughout the study
- Study-related monitoring of health and follow-up care
- Travel and other study-related expenses may be reimbursed